How to choose the right controlled pore glass (CPG) solid support for therapeutic development.| blog.biosearchtech.com
Find out why we are excited about GalNAc as a means of delivering siRNAs and other therapeutic oligos to the liver.| blog.biosearchtech.com
Nucleic acid therapeutics use synthetic oligonucleotides to achieve long-lasting or curative effects through gene inhibition, addition, replacement or editing. This blog series explores how oligo modifications can enable therapeutic applications.| blog.biosearchtech.com
Oligo therapeutics have improved, with 18 therapies approved in 2023; more in late-stage development. ASO and siRNA are promising technologies. Learn more| blog.biosearchtech.com